The Trust Layer for Market Analysts

The stock HIMS has shown a significant bullish trend over the past five days, driven by positive news regarding the acquisition of a US-based peptide facility and the success of its weight-loss products. The company's growth in subscriber numbers and expansion into international markets, coupled with a decreasing short interest, indicate a strong positive outlook. The stock is currently trading at a P/S ratio of 1.8x, which is considered cheap for a growth stock, suggesting potential for further upside. The company's guidance for 2030 revenue and adjusted EBITDA further supports a bullish thesis, with the stock showing a significant growth potential over the next 4-5 years.